Fathollah Riahi

1.1k total citations
15 papers, 879 citations indexed

About

Fathollah Riahi is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Fathollah Riahi has authored 15 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 9 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Fathollah Riahi's work include Antimicrobial Resistance in Staphylococcus (9 papers), Pneumonia and Respiratory Infections (8 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Fathollah Riahi is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (9 papers), Pneumonia and Respiratory Infections (8 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Fathollah Riahi collaborates with scholars based in United States, Iran and Belgium. Fathollah Riahi's co-authors include Kristopher P. Heilmann, Gary V. Doern, Cassie L. Dohrn, Sandra S. Richter, Daniel J. Diekema, Susan E. Beekmann, S. Tendolkar, Jennifer S. McDanel, Sandra S. Richter and Andrew J. Costello and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Fathollah Riahi

14 papers receiving 854 citations

Peers

Fathollah Riahi
Cassie L. Dohrn United States
Fathollah Riahi
Citations per year, relative to Fathollah Riahi Fathollah Riahi (= 1×) peers Cassie L. Dohrn

Countries citing papers authored by Fathollah Riahi

Since Specialization
Citations

This map shows the geographic impact of Fathollah Riahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fathollah Riahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fathollah Riahi more than expected).

Fields of papers citing papers by Fathollah Riahi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fathollah Riahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fathollah Riahi. The network helps show where Fathollah Riahi may publish in the future.

Co-authorship network of co-authors of Fathollah Riahi

This figure shows the co-authorship network connecting the top 25 collaborators of Fathollah Riahi. A scholar is included among the top collaborators of Fathollah Riahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fathollah Riahi. Fathollah Riahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Richter, Sandra S., Gary V. Doern, Kristopher P. Heilmann, et al.. (2016). Detection and Prevalence of Penicillin-Susceptible Staphylococcus aureus in the United States in 2013. Journal of Clinical Microbiology. 54(3). 812–814. 28 indexed citations
2.
Richter, Sandra S., Daniel J. Diekema, Kristopher P. Heilmann, et al.. (2014). Changes in Pneumococcal Serotypes and Antimicrobial Resistance after Introduction of the 13-Valent Conjugate Vaccine in the United States. Antimicrobial Agents and Chemotherapy. 58(11). 6484–6489. 129 indexed citations
3.
Riahi, Fathollah, Mohammad Derakhshan, Arman Mosavat, Saman Soleimanpour, & Seyed Abdolrahim Rezaee. (2014). Evaluation of Point Mutation Detection in Mycobacterium tuberculosis with Isoniazid Resistance Using Real-Time PCR and TaqMan Probe Assay. Applied Biochemistry and Biotechnology. 175(5). 2447–2455. 12 indexed citations
4.
Diekema, Daniel J., Sandra S. Richter, Kristopher P. Heilmann, et al.. (2014). Continued Emergence of USA300 Methicillin-ResistantStaphylococcus aureusin the United States: Results from a Nationwide Surveillance Study. Infection Control and Hospital Epidemiology. 35(3). 285–292. 133 indexed citations
5.
Diekema, Daniel J., Sandra S. Richter, L. Boyken, et al.. (2014). 297Trends in Staphylococcus aureus (SA) Isolation in 28 US Hospitals, 2009-2013. Open Forum Infectious Diseases. 1(suppl_1). S124–S124.
6.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2013). Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–20111. Emerging infectious diseases. 19(7). 1074–1083. 188 indexed citations
7.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2013). Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines. 27 indexed citations
8.
Richter, Sandra S., Daniel J. Diekema, Kristopher P. Heilmann, et al.. (2013). Activities of Vancomycin, Ceftaroline, and Mupirocin against Staphylococcus aureus Isolates Collected in a 2011 National Surveillance Study in the United States. Antimicrobial Agents and Chemotherapy. 58(2). 740–745. 33 indexed citations
9.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2013). Evaluation of Pneumococcal Serotyping by Multiplex PCR and Quellung Reactions. Journal of Clinical Microbiology. 51(12). 4193–4195. 20 indexed citations
10.
Doern, Gary V., Daniel J. Diekema, Kristopher P. Heilmann, et al.. (2012). In Vitro Activity of Ceftaroline against Clinical Isolates of Streptococcus pneumoniae Recovered in 43 U.S. Medical Centers during 2010-2011. Antimicrobial Agents and Chemotherapy. 56(6). 3406–3408. 7 indexed citations
11.
Richter, Sandra S., Sarah W. Satola, Emily K. Crispell, et al.. (2011). Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States. Journal of Clinical Microbiology. 49(12). 4203–4207. 47 indexed citations
12.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2011). Activity of Ceftaroline and Epidemiologic Trends in Staphylococcus aureus Isolates Collected from 43 Medical Centers in the United States in 2009. Antimicrobial Agents and Chemotherapy. 55(9). 4154–4160. 56 indexed citations
13.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2008). Accuracy of Phenotypic Methods for Identification of Streptococcus pneumoniae Isolates Included in Surveillance Programs. Journal of Clinical Microbiology. 46(7). 2184–2188. 44 indexed citations
14.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2008). Increasing telithromycin resistance among Streptococcus pyogenes in Europe. Journal of Antimicrobial Chemotherapy. 61(3). 603–611. 37 indexed citations
15.
Richter, Sandra S., Kristopher P. Heilmann, Cassie L. Dohrn, et al.. (2008). Changing Epidemiology of Antimicrobial‐ResistantStreptococcus pneumoniaein the United States, 2004–2005. Clinical Infectious Diseases. 48(3). e23–e33. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026